GRI Bio, Inc. (GRI)
NASDAQ: GRI · Real-Time Price · USD
1.380
-0.020 (-1.43%)
At close: Oct 16, 2026, 4:00 PM EDT
1.420
+0.040 (2.90%)
After-hours: Oct 16, 2026, 7:12 PM EDT
GRI Bio Market Cap
GRI Bio has a market cap or net worth of $3.02 million as of October 16, 2026. It is the 46,815th most valuable company in the world and the 6,265th biggest in the United States. Its market cap has decreased by 40.33% in one year.
Market Cap
3.02M
Enterprise Value
-7.89M
1-Year Change
-40.33%
Global Rank
Country Rank
#6,265 United States
Category
ChartMarket Cap Chart
Since April 24, 2023, GRI Bio's market cap has decreased from $25.29M to $3.02M, a decrease of -88.07%. That is a compound annual growth rate of -45.70%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 16, 2026 | 3.02M | 20.78% |
| Dec 31, 2025 | 2.50M | -66.25% |
| Dec 31, 2024 | 7.40M | 326.73% |
| Dec 29, 2023 | 1.73M | -93.14% |
| Apr 24, 2023 | 25.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Moolec Science | 3.66M |
| Dermata Therapeutics | 3.63M |
| KALA BIO | 3.62M |
| Ernexa Therapeutics | 3.33M |
| Addex Therapeutics | 3.31M |
| Eocene | 3.10M |
| 60 Degrees Pharmaceuticals | 3.08M |
| Calidi Biotherapeutics | 2.96M |